Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2368]
News [5629]
Articles [137]
Editorials [4]
Conferences [165]
elearning [13]
Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia
Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia
ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
ASH 2025: Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
ASH 2025: Continuous and fixed-duration treatments result in similar outcomes for CLL
ASH 2025: Continuous and fixed-duration treatments result in similar outcomes for CLL
A routine blood test could help predict who benefits most from CAR T-cell therapy
A routine blood test could help predict who benefits most from CAR T-cell therapy
ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma
ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma
ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially preventable
ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially...
ASH 2025: Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukaemia patients eligible for intensive chemotherapy
ASH 2025: Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukaemia patients...
Could altering the daily timing of immunotherapy improve survival in people with cancer?
Could altering the daily timing of immunotherapy improve survival in people with cancer?
Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers
Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers
CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer development
CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation